12 Mar, 2020

Statement from ACI founder Steve Moore

It has been quite a start to 2020 across our sector, with significant regulatory developments in both the medicinal cannabis and the CBD wellness space.

However, right now we all have to adapt to a new world and the unprecedented challenge a global pandemic presents us all.

11 Mar, 2020

New Poll Finds Overwhelming Public Support For FSA CBD Regulation

A new YouGov poll commissioned by The Association for the Cannabinoid Industry demonstrates overwhelming support for recent FSA guidance concerning CBD

19 Feb, 2020

FAQ for CBD Consumers, Retailers, Manufacturers and Health Care Professionals

Following the FSA’s recent announcement, relating to CBD regulation and precautionary health advice, ACI’s experts have compiled the following FAQ covering the questions consumers, retailers, manufacturers or health care professionals may have concerning CBD.

14 Feb, 2020

ACI Regulatory and Compliance Lead Dr Parveen Bhatarah Responds to Questions Relating to FSA CBD Guidelines

In the aftermath of the FSA’s announcement relating to CBD regulation and precautionary health advice, the ACI’s Regulatory Lead, Dr Parveen Bhatarah, has compiled the following answers to some of the common questions being posed to the ACI.  Please note: We are also in the process of compiling a more indepth FAQ which we will […]

13 Feb, 2020

FSA Provides Clear Regulatory Guidance for the UK CBD Industry

The Association for the Cannabinoid Industry (ACI) today welcomes the new regulatory and precautionary advice published by the Food Standards Agency (FSA).

16 Jan, 2020

ACI Statement on BBC Two’s Trust Me I’m a Doctor CBD Testing Results

On the 15th January BBC Two aired a segment on their popular science show Trust Me I’m a Doctor which investigated twelve popular CBD products available in the UK over the counter and online.

19 Dec, 2019

Response from the ACI on the speculation on Article 4 concerning FSA’s stance on Novel Foods

Article 4 is a specific provision which allows companies to consult with competent authorities (e.g. The UK FSA) to establish if the product they wish to sell on the market is in fact novel.

11 Dec, 2019

ACI Respond to NPA Statement in CBD Regulation

Steve Moore, ACI Strategic Counsel has today responded to the National Pharmacy Association’s advisory statement regarding CBD products in pharmacies with the following statement:

10 Dec, 2019

ACI to Commence Novels Foods Applications for our Members

Deadline for acknowledgement of engagement from ACI members in the Novel Foods application process set to 20 December. This is the first major step towards a fully-compliant CBD industry in the UK.

3 Dec, 2019

Association for the Cannabinoid Industry announced as a Diamond Sponsor at The Grocer’s inaugural CBD Global Summit in spring 2020

The Association for the Cannabinoid Industry (ACI) is delighted to announce its partnership with The Grocer as a diamond sponsor for the publication’s first ever CBD Global Summit on the 16th-17th March 2020.

3 Dec, 2019

ACI Announces New Onboarding Process

Following the successful launch of the ACI in November 2019, the ACI has announced plans to host evening briefing sessions for prospective new members.

20 Nov, 2019

Fresh data revealed at launch of the ACI shows lack of regulation is barrier to consumer trust in the industry

Friday 8th November saw the launch of a ground-breaking new industry body to foster a legally compliant, socially responsible and innovative cannabinoid industry – The Association for the Cannabinoid Industry (ACI).